Literature DB >> 31456416

Parkin Regulates Programmed Necrosis and Myocardial Ischemia/Reperfusion Injury by Targeting Cyclophilin-D.

Teng Sun1, Wei Ding2, Tao Xu1, Xiang Ao1, Tao Yu1, Mengyang Li3, Ying Liu1, Xuejuan Zhang2, Lin Hou3, Jianxun Wang1,3.   

Abstract

Aims: Cardiomyocyte death critically contributes to the pathogenesis of cardiac disorders, such as myocardial infarction, heart failure, and cardiac ischemia/reperfusion (I/R) injury. As one of the main forms of cardiac cell death, necrosis plays a critical role in heart diseases. Multiple signaling pathways of necrosis have been demonstrated, in which death receptors, receptor-interacting serine/threonine-protein 1 and 3 kinases, and cyclophilin-D (CypD) have been deeply implicated. However, the fundamental mechanism underlying myocardial necroptosis, especially the mitochondrial permeability transition pore (mPTP)-CypD-dependent death pathway, is poorly understood. Parkin functions as an E3 ubiquitin protein ligase that mainly mediates mitophagy cascades. As yet, it is not clear whether Parkin participates in regulating necrosis and myocardial I/R injury.
Results: Here, our results showed that Parkin mediated mitophagy and inhibited necrosis under oxidative stress. In further exploring the underlying mechanisms, we found that Parkin suppressed mPTP opening by catalyzing the ubiquitination of CypD in necrotic cascades, which were not involved in Parkin-regulated mitophagy. Parkin inhibited necrosis, reduced myocardial I/R injury, and improved cardiac function. Innovation: Our present work reveals a highlighted connection between the mitochondrial matrix-localized Parkin and the mPTP-CypD-dependent necrotic signaling pathway in cardiac injury.
Conclusion: Our results revealed a novel myocardial necrotic regulating model composed of Parkin, CypD, and mPTP, which may provide potential therapeutic targets and strategies to modulate the levels of these molecules.

Entities:  

Keywords:  CypD; Parkin; mPTP; myocardial ischemia/reperfusion injury; programmed necrosis

Year:  2019        PMID: 31456416     DOI: 10.1089/ars.2019.7734

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  23 in total

Review 1.  Insight into Crosstalk Between Mitophagy and Apoptosis/Necroptosis: Mechanisms and Clinical Applications in Ischemic Stroke.

Authors:  Yan-di Yang; Zi-Xin Li; Xi-Min Hu; Hao Wan; Qi Zhang; Rui Xiao; Kun Xiong
Journal:  Curr Med Sci       Date:  2022-04-07

Review 2.  Mitochondrial quality control in cardiac ischemia/reperfusion injury: new insights into mechanisms and implications.

Authors:  Yang Bai; Jinjing Wu; Zhenyu Yang; Xu'an Wang; Dongni Zhang; Jun Ma
Journal:  Cell Biol Toxicol       Date:  2022-08-11       Impact factor: 6.819

Review 3.  Cyclophilin D: Guardian or Executioner for Tumor Cells?

Authors:  Ling Zhang; Yi Liu; Rou Zhou; Baoyu He; Wenjun Wang; Bin Zhang
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

Review 4.  Compositions and Functions of Mitochondria-Associated Endoplasmic Reticulum Membranes and Their Contribution to Cardioprotection by Exercise Preconditioning.

Authors:  Yuhu Lv; Lin Cheng; Fenglin Peng
Journal:  Front Physiol       Date:  2022-06-06       Impact factor: 4.755

Review 5.  Molecular mechanisms and consequences of mitochondrial permeability transition.

Authors:  Massimo Bonora; Carlotta Giorgi; Paolo Pinton
Journal:  Nat Rev Mol Cell Biol       Date:  2021-12-08       Impact factor: 113.915

6.  Perspective: Low Risk of Parkinson's Disease in Quasi-Vegan Cultures May Reflect GCN2-Mediated Upregulation of Parkin.

Authors:  Mark F McCarty; Aaron Lerner
Journal:  Adv Nutr       Date:  2021-03-31       Impact factor: 8.701

7.  Mitochondrial fission and mitophagy are independent mechanisms regulating ischemia/reperfusion injury in primary neurons.

Authors:  Anthony R Anzell; Garrett M Fogo; Zoya Gurm; Sarita Raghunayakula; Joseph M Wider; Kathleen J Maheras; Katlynn J Emaus; Timothy D Bryson; Madison Wang; Robert W Neumar; Karin Przyklenk; Thomas H Sanderson
Journal:  Cell Death Dis       Date:  2021-05-12       Impact factor: 8.469

8.  Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover.

Authors:  Juliana de F Germano; Chengqun Huang; Jon Sin; Yang Song; Kyle C Tucker; David J R Taylor; Hannaneh Saadaeijahromi; Aleksandr Stotland; Honit Piplani; Roberta A Gottlieb; Robert M Mentzer; Allen M Andres
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 9.  Mitochondrial Quality Control: Role in Cardiac Models of Lethal Ischemia-Reperfusion Injury.

Authors:  Andrew R Kulek; Anthony Anzell; Joseph M Wider; Thomas H Sanderson; Karin Przyklenk
Journal:  Cells       Date:  2020-01-15       Impact factor: 6.600

Review 10.  Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside.

Authors:  Namrita Kaur; Rida Raja; Andrea Ruiz-Velasco; Wei Liu
Journal:  Front Cardiovasc Med       Date:  2020-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.